Efficacy and safety of cilazapril in elderly patients with essential hypertension: A multicenter study

I Kobrin, D Ben-Ishay, R Bompani, R Dixon… - The American journal of …, 1989 - Elsevier
safety of cilazapril monotherapy in elderly patients with uncomplicated essential hypertension
Fairhurst G, eta/: Safety and efficacy of enalapril in essential hypertension in the elderly, Br …

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide

G Hegner, G Faust, F Freytag, S Meilenbrock… - European journal of …, 1997 - Springer
… A direct comparison of the efficacy and safety with diuretics has … efficacy of valsartan 80 mg
with hydrochlorothiazide 25 mg in the treatment of mild to moderate essential hypertension. A …

Efficacy and safety of imidapril in patients with essential hypertension: a double-blind comparison with captopril

PJ Huang, KL Chien, MF Chen, LP Lai, FT Chiang - Cardiology, 2001 - karger.com
essential hypertension ranging in age from 30 to 70 years were eligible to participate in this
study. Mild to moderate hypertension … renal disease and secondary hypertension. All patients …

Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized …

A Mugellini, J Dobovisek, D Planinc, G Cremonesi… - Clinical …, 2004 - Elsevier
… There have been few studies comparing the efficacy and … was to compare the antihypertensive
efficacy and tolerability of … with mild to moderate essential hypertension. METHODS:: This …

Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a …

JJ Mourad, C Amodeo, M de Champvallins… - … of Hypertension, 2017 - journals.lww.com
… /indapamide/amlodipine single pill over perindopril/indapamide after 1 month and to
determine further up-titration efficacy and safety in patients with mild-to-moderate hypertension. …

Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension

JM Mallion, S Omboni, J Barton, W Van Mieghem… - Blood …, 2011 - Taylor & Francis
… Mild to moderate treated or untreated essential hypertensive outpatients of either gender,
aged 65–89 years, were eligible for study participation. Hypertension was defined according to …

… , double-blind, placebo-controlled, phase IIa, clinical study on investigating the efficacy and safety of SPH3127 tablet in patients with essential hypertension

F Wang, L Liu, H Ruan, X Chen, Y Zhang, Z Yu… - Hypertension …, 2024 - nature.com
… to investigate the efficacy and safety of SPH3127 in patients with essential hypertension.
This study was conducted in patients with mild to moderate essential hypertension, utilizing a …

Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension

T Saruta, T Ogihara, H Matsuoka, H Suzuki… - Hypertension …, 2007 - nature.com
… the antihypertensive efficacy of 8-week treatment with three different fixed-dose combinations
of losartan plus hydrochlorothiazide in Japanese patients with essential hypertension. The …

Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel …

J Lin, Q Wang, D Zhong, J Zhang, T Yuan… - Frontiers in …, 2023 - frontiersin.org
… treatment for hypertension. This study aimed to investigate the antihypertensive efficacy
and safety of QDT combined with amlodipine besylate in patients with essential hypertension. …

Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension

LM Ruilope - Vascular Health and Risk Management, 2008 - Taylor & Francis
efficacy of the combination of olmesartan and HCTZ, including dose-responsiveness, long-…
efficacy, goal rate achievement, and efficacy in patients with moderate to severe hypertension